Interesting article on Alpha that described POZN's marketing strategy that by passes pharmco sales rep and relies on a social media/marketing approach. What's not certain is whether physicians will use this method to review drugs and influence their prescription writing habits. Apparently physician utilization of this marketing strategy is still early and its not clear what level of adoption will finally occur.
Yes as far as Treximet and Vimovo, but generics might not go after PA, because of its low cost. It is easy to go after the Treximet with its $30 per pill price. Try to do the same with the $20 per 30 pills PA. Will not be cost-effective for generics considering the letigation expense.